Explore All Access
Check if your research matches the topics covered in American Journal of Cardiovascular Drugs?
- Degree of match
- Common matching concepts
- Additional journal recommendations
American Journal of Cardiovascular Drugs : Impact Factor & More
eISSN: 1179-187XpISSN: 1175-3277
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
American Journal of Cardiovascular Drugs Key Metrics
CiteScore 
5.9
Eigenfactor
0.001 - 0.005
H-Index
57
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.15
Topics Covered on American Journal of Cardiovascular Drugs
Myocardial infarction
Hypertonic saline
Atrial fibrillation
Anticoagulant
Meta-analysis
Warfarin
Aspirin
Ticagrelor
Heart failure
Major bleeding
Confidence interval
Rivaroxaban
Cardiovascular death
Lipid-lowering therapy
Blood pressure
Systematic review
Prasugrel
Percutaneous coronary intervention
Furosemide
Heparin
American Journal of Cardiovascular Drugs Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in American Journal of Cardiovascular Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in American Journal of Cardiovascular Drugs
Safety of Vericiguat in Patients with Coronary Artery Disease: A Systematic Review and Meta-analysis.
- 6 Dec 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
A Systematic Review and Meta-Analysis of the Safety and Efficacy of SGLT2 Inhibitors in Chronic Heart Failure in ACHD Patients.
- 2 Dec 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Role of Incretin Mimetics in Cardiovascular Outcomes and Other Classical Cardiovascular Risk Factors beyond Obesity and Diabetes Mellitus in Nondiabetic Adults with Obesity: a Meta-analysis of Randomized Controlled Trials.
- 30 Nov 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
A Meta-analysis of the Regulation of Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin-Kexin Type 9 with Inclisiran.
- 29 Nov 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Real-Life Individual Comparison of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure and Diabetes Mellitus.
- 28 Nov 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Impact of Renal Function Estimation Formulae on Use and Correct Dosing of NOACs in Patients with Non-valvular Atrial Fibrillation in Real Life in Germany.
- 26 Nov 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Safety of Vericiguat in Patients with Coronary Artery Disease: A Systematic Review and Meta-analysis.
- 6 Dec 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
A Systematic Review and Meta-Analysis of the Safety and Efficacy of SGLT2 Inhibitors in Chronic Heart Failure in ACHD Patients.
- 2 Dec 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Role of Incretin Mimetics in Cardiovascular Outcomes and Other Classical Cardiovascular Risk Factors beyond Obesity and Diabetes Mellitus in Nondiabetic Adults with Obesity: a Meta-analysis of Randomized Controlled Trials.
- 30 Nov 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
A Meta-analysis of the Regulation of Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin-Kexin Type 9 with Inclisiran.
- 29 Nov 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Real-Life Individual Comparison of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure and Diabetes Mellitus.
- 28 Nov 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Impact of Renal Function Estimation Formulae on Use and Correct Dosing of NOACs in Patients with Non-valvular Atrial Fibrillation in Real Life in Germany.
- 26 Nov 2024
- American journal of cardiovascular drugs : drugs, devices, and other interventions
Compare Similar Journals with American Journal of Cardiovascular Drugs
Select Journals to Compare with American Journal of Cardiovascular Drugs
Total journals - 9
You can select up to 3 Journals at a time
European Heart Journal
Publisher: OXFORD UNIV PRESS
Journal of the American College of Cardiology
Publisher: ELSEVIER SCIENCE INC
Circulation
Publisher: LIPPINCOTT WILLIAMS & WILKINS
International Journal of Cardiology
Publisher: ELSEVIER IRELAND LTD
Journal of the American Heart Association
Publisher: WILEY
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Journal of Clinical Medicine
Publisher: MDPI
Medicine
Publisher: Elsevier
European Journal of Preventive Cardiology
Publisher: OXFORD UNIV PRESS
0 Journals Selected to compare with
American Journal of Cardiovascular Drugs
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on American Journal of Cardiovascular Drugs
How long has American Journal of Cardiovascular Drugs been actively publishing? 
American Journal of Cardiovascular Drugs has been in operation since 2001 till date.
What is the publishing frequency of American Journal of Cardiovascular Drugs?
American Journal of Cardiovascular Drugs published with a Bi-monthly frequency.
How many articles did American Journal of Cardiovascular Drugs publish last year?
In 2023, American Journal of Cardiovascular Drugs publsihed 62 articles.
What is the eISSN & pISSN for American Journal of Cardiovascular Drugs?
For American Journal of Cardiovascular Drugs, eISSN is 1179-187X and pISSN is 1175-3277.
What is Citescore for American Journal of Cardiovascular Drugs?
Citescore for American Journal of Cardiovascular Drugs is 5.9.
What is the H Index for American Journal of Cardiovascular Drugs ?
H Index for American Journal of Cardiovascular Drugs is 57.
What is SNIP score for American Journal of Cardiovascular Drugs?
SNIP score for American Journal of Cardiovascular Drugs is 1.15.
What is the SJR for American Journal of Cardiovascular Drugs?
SJR for American Journal of Cardiovascular Drugs is Q2.
Who is the publisher of American Journal of Cardiovascular Drugs?
ADIS INT LTD is the publisher of American Journal of Cardiovascular Drugs.
